City University of New York into the of faculty member and Alzheimer's researcher Hoau-Yan Wang, PhD, citing concerns about the integrity of the investigation. (New York Times, Science)
The EMBARK pivotal study of delandistrogene moxeparvovec (Elevidys) in Duchenne muscular dystrophy, Sarepta Therapeutics said. In June, the FDA granted accelerated approval to the one-time gene therapy.
Higher were tied to lower dementia risk, prospective data from the ASPREE trial showed. (Neurology)
A virtual tai chi program in older adults with mild cognitive impairment. (Annals of Internal Medicine)
Fine particulate matter in regional hot spots was among Medicare beneficiaries. (Neurology)
A 6-week with four booster sessions was superior to standard care alone in treating multiple sclerosis fatigue. (Journal of Neurology, Neurosurgery, and Psychiatry)
Systolic in older age, but not in midlife, was linked with higher dementia risk. (JAMA Network Open)
Three rare genetic variants with large effects shed light on the subtypes. (Nature Genetics)
The targeted C5 complement inhibitor zilucoplan (Zilbrysq) was approved to treat , drugmaker UCB announced.
Adverse events in childhood were risk factors for in adulthood, a meta-analysis suggested. (Neurology)